SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-23-051444
Filing Date
2023-04-27
Accepted
2023-04-27 16:48:18
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm231938d3_defa14a.htm DEFA14A 11209
2 GRAPHIC tm231938d3_defa14aimg001.jpg GRAPHIC 161067
3 GRAPHIC tm231938d3_defa14aimg002.jpg GRAPHIC 143874
  Complete submission text file 0001104659-23-051444.txt   432410
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34620 | Film No.: 23858003
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences